Seoul, South Korea

Suhkneung Pyo

USPTO Granted Patents = 1 

Average Co-Inventor Count = 13.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suhkneung Pyo: Innovator in Pharmaceutical Composition

Introduction

Suhkneung Pyo is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the prevention and treatment of inflammatory and immune diseases. His innovative work focuses on utilizing natural compounds to develop effective therapeutic solutions.

Latest Patents

Suhkneung Pyo holds a patent for a pharmaceutical composition that contains Ramalin, a compound isolated from Antarctic lichen. This invention highlights the anti-inflammatory activity of Ramalin, which is non-toxic and free from side effects. The composition effectively inhibits the expression of inducible nitric oxide synthase (iNOS) and significantly reduces the production of nitric oxide, a key mediator in inflammatory responses. Additionally, it inhibits the activation of inflammatory mediators and various signaling pathways, suggesting its potential for treating or preventing inflammatory and immune diseases.

Career Highlights

Suhkneung Pyo is affiliated with the Korea Ocean Research and Development Institute, where he continues to advance his research in pharmaceutical innovations. His work emphasizes the importance of natural materials in developing effective medical treatments.

Collaborations

Suhkneung Pyo collaborates with esteemed colleagues, including Joung Han Yim and Il Chan Kim, to further enhance the impact of his research and innovations.

Conclusion

Suhkneung Pyo's contributions to pharmaceutical compositions demonstrate the potential of natural compounds in medical applications. His innovative approach to treating inflammatory diseases positions him as a key figure in the field of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…